Mporium Share Discussion Threads

[markinthepark] 25/6/2008 12:11

I see the directors have voted themselves some more free (35p options) shares to show their "commitment" to achieving a return for shareholders here....at some point in the next 5 years or eventually.....

[daveelectec] 13/6/2008 12:15

HERE HERE. MARK

[markinthepark] 11/6/2008 15:38

The same story was in the Times as well.....trouble is as that usual any prospects for this are still years away...company will probably go bust in the meantime or get taken over on the cheap....they might even try and get a rights issue away on the back of that story if there are enough mugs out there to keep this lot employed.....a total and utter disaster for PIs from the word go this one.....this whole thing is just a never ending research project, not a plc.....

[brownrock] 11/6/2008 10:01

New migraine drug that could completely dispel symptoms for thousands of sufferers

By Jenny Hope
Last updated at 12:20 AM on 11th June 2008 daily mail online

[brownrock] 11/6/2008 09:59

Hi just read a very positive report about this in the daily mail today

[vuelands] 06/6/2008 20:01

This outfit will fail because (1] they will run out of money,(2}Dr sharp never keeps to his deadlines,(3)he does not keep his few shareholders informed,(4) there is no prospect of real earnings in the near future. Under 10p in the next 6 months, and thats after consolidation.Sell sell sell.

[daveelectec] 28/5/2008 14:55

Any views on this outstandingly good news anyone ?

[naz4] 25/4/2008 12:04

any opinion on minster

[naz4] 13/3/2008 10:59

even when there is good news ,the share price gets draged down why ?.

[sand dollar] 12/3/2008 08:51

Minster Pharmaceuticals says tonabersat trial for migraine with Aura enrolled

LONDON (Thomson Financial) - Minster Pharmaceuticals PLC said the phase II
trial in Denmark for its key migraine drug has been fully enrolled, with the
results expected in the second half of this year.
The trial of the drug tonabersat is for the prevention of migraine with
aura, a type of migraine in which the headache is accompanied by symptoms such
as flashing lights and abnormality of speech.
The trial, which is being conducted at the Danish Headache Centre at
Copenhagen's Glostrup University Hospital, is being jointly funded by Minster
and the University of Copenhagen.
Minster is also currently enrolling a phase IIb trial in the US for the use
of tonabersat for the preventive treatment of migraines.
Last month it announced it had so far enrolled around a quarter of the
patients planed for the trial, leaving it on track to report by the end of the
fourth quarter.
[e-mail]
tc

[naz4] 31/12/2007 23:09

well nice to hear from you spitfire ,he has surley done he;s job ,but were do we go from hear.and wish you a happy new year

[spitfire3] 31/12/2007 18:11

ask harry the paid ramper....??? his job is done

[naz4] 26/11/2007 21:38

you are right ,but any news on mpm,rosca,do you belive we are in for long term

[markinthepark] 28/9/2007 11:35

Minster Pharmaceuticals plc (AIM: MPM) announces that, on 27 September 2007,
Jerry Karabelas, a Non-executive Director of the Company, was granted an option
over 200,000 ordinary shares of 5p each at an exercise price of 46.75 p per
ordinary share.

This option is exercisable in full during the period commencing
on the second anniversary of the date of grant and terminating on the fifth
anniversary of the date of grant, subject to the continued tenure of Dr
Karabelas with the Company as a Non-executive Director.

Following the grant of the option referred to above, Dr Karabelas is interested
in 200,000 ordinary shares of 5p each in the ordinary share capital of the
Company, representing 0.34% of the Company's issued ordinary share capital as at 28 September 2007.

[naz4] 27/9/2007 23:19

there was a comment made yesterday ,but can not find it.

[naz4] 18/9/2007 23:18

the idea of this thread is to discuss mpm ,not some b---- s--- about some court case , is there any view on mpm shares ,there seems to be no recovery in these shares at all.